|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental Studies |
1 From the Center for Cardiovascular Magnetic Resonance, Department of Medicine, Cardiovascular Division, Washington University Medical School, St Louis, Mo (S.F., J.S.A., J.M.C., C.H.L.); and Imaging Division, Mallinckrodt, St Louis, Mo (J.H.W., M.P.P., M.D.A., I.K.A.). Received March 4, 2002; revision requested April 23; final revision received July 31; accepted August 14. S.F. supported by German Research Foundation grant FL-330. Address correspondence to S.F., Department of Radiology, University of Bonn, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany (e-mail: flacke@uni-bonn.de).
PURPOSE: To determine the contrast agent behavior of gadolinium-based (extracellular and albumin-binding) and manganese-based contrast media for late-enhancement imaging of myocardial infarction.
MATERIALS AND METHODS: Coronary ligation was performed in 30 rats, and they were serially imaged with segmented inversion-recovery gradient-echo magnetic resonance (MR) imaging (repetition time msec/echo time msec/inversion time msec [fixed], 5.2/2.5/430; flip angle, 15°) during 1 hour after administration of contrast media by using a 1.5-T MR unit. Serial measurements of the longitudinal relaxation were performed by using the Look-Locker approach (repetition time msec/echo time msec, 1,000/3.5; flip angle, 10°). Detection and size of infarction were evaluated at each time point and compared with end-point histologic findings.
RESULTS: For all manganese-based media, the contrast agent cleared from the blood pool rapidly. Manganese-based contrast media allowed precise labeling of viable cardiomyocytes within 30 minutes, and the labeling persisted for at least 1 hour. Accumulation of gadoversetamide in the infarct area was apparent after 5 minutes, and the peak contrast-to-noise ratio (CNR) between infarct and myocardium was comparable to the peak CNR of manganese-based contrast agents. Extracellular gadopentetate dimeglumine provided excellent infarct detection but a small imaging window for precise sizing of the infarct if a fixed inversion time of 430 msec was used. Albumin-binding gadolinium-based contrast media provided a longer imaging window, but infarct size was overestimated because of the nonspecific distribution of the unbound gadolinium agent.
CONCLUSION: When extracellular gadolinium-based agents are used for infarct size measurement, imaging parameters and timing are important because the kinetics of both normal and irreversibly injured myocardium must be considered. Manganese-based agents are highly specific and less sensitive to timing for infarct size determination, but further studies are required to determine if they are feasible for human use.
© RSNA, 2003
Index terms: Contrast media, comparative studies Contrast media, experimental studies Magnetic resonance (MR), contrast media, 511.121412, 511.121413, 511.12143 Manganese Myocardium, infarction, 511.771
This article has been cited by other articles:
![]() |
N. Ojha, S. Roy, J. Radtke, O. Simonetti, S. Gnyawali, J. L. Zweier, P. Kuppusamy, and C. K. Sen Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2435 - H2443. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Higuchi, S. G. Nekolla, A. Jankaukas, A. W. Weber, M. C. Huisman, S. Reder, S. I. Ziegler, M. Schwaiger, and F. M. Bengel Characterization of Normal and Infarcted Rat Myocardium Using a Combination of Small-Animal PET and Clinical MRI J. Nucl. Med., February 1, 2007; 48(2): 288 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Huber, S. O. Schoenberg, C. Hayes, B. Spannagl, M. G. Engelmann, W. M. Franz, and M. F. Reiser Phase-Sensitive Inversion-Recovery MR Imaging in the Detection of Myocardial Infarction Radiology, December 1, 2005; 237(3): 854 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Natanzon, A. H. Aletras, L.-Y. Hsu, and A. E. Arai Determining Canine Myocardial Area at Risk with Manganese-enhanced MR Imaging Radiology, September 1, 2005; 236(3): 859 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Krombach, J. G. Pfeffer, S. Kinzel, M. Katoh, R. W. Gunther, and A. Buecker MR-guided Percutaneous Intramyocardial Injection with an MR-compatible Catheter: Feasibility and Changes in T1 Values after Injection of Extracellular Contrast Medium in Pigs Radiology, May 1, 2005; 235(2): 487 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Edelman Contrast-enhanced MR Imaging of the Heart: Overview of the Literature Radiology, September 1, 2004; 232(3): 653 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, S. S. Berr, W. D. Gilson, M.-C. Toufektsian, and B. A. French Simultaneous Evaluation of Infarct Size and Cardiac Function in Intact Mice by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Reveals Contractile Dysfunction in Noninfarcted Regions Early After Myocardial Infarction Circulation, March 9, 2004; 109(9): 1161 - 1167. [Abstract] [Full Text] [PDF] |
||||